Frank D. Heuszel
Chief Executive Officer at DSS Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: DSS Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Impact BioMedical Inc. November 5, 202599.9%
-
DSS Inc. October 25, 202394.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 2024 | Impact BioMedical Inc. | Open-market purchase | +500 | $2.26 | $1,130 |
| Nov 27, 2024 | Impact BioMedical Inc. | Open-market purchase | +500 | $2.61 | $1,305 |
| Nov 26, 2024 | Impact BioMedical Inc. | Open-market purchase | +550 | $2.63 | $1,447 |
| Nov 26, 2024 | Impact BioMedical Inc. | Open-market purchase | +500 | $2.59 | $1,295 |
| Apr 10, 2023 | DSS Inc. | Grant or award | +1,247,078 | $0.22 | $274,357 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.